Similar articles

• Transrectal ultrasound and prostate-specific antigen in prostate cancer.

  Lavoipierre AM. Lavoipierre AM. J Med Imaging Radiat Oncol. 2008 Oct;52(5):530. doi: 10.1111/j.1440-1673.2008.02009.x. J Med Imaging Radiat Oncol. 2008. PMID: 19032406 No abstract available.
• Prostate cancer: is the PSA test the answer?

  Berlin B. Berlin B. N J Med. 1998 Mar;95(3):53-5. N J Med. 1998. PMID: 16013148 Review. No abstract available.
• Re: Al-Azab R, Toi A, Lockwood G, et al. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL (Urology 69:103-107, 2007).

  Stephan C, Jung K, Lein M, Deger S. Stephan C, et al. Urology. 2008 Oct;72(4):951. doi: 10.1016/j.urology.2007.07.079. Urology. 2008. PMID: 18926253 No abstract available.
• Re: The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma.

  Pitts WR Jr. Pitts WR Jr. J Urol. 1995 Mar;153(3 Pt 1):752. doi: 10.1097/00005392-199503000-00064. J Urol. 1995. PMID: 7532238 No abstract available.
• Prostate-specific antigen testing for early diagnosis of prostate cancer: formulation of guidelines.

  Carter HB, Pearson JD. Carter HB, et al. Urology. 1999 Nov;54(5):780-6. doi: 10.1016/s0090-4295(99)00271-x. Urology. 1999. PMID: 10565733 Review. No abstract available.